LOGIN  |  REGISTER
C4 Therapeutics

Hamilton Thorne (TSX: HTL) Stock Quote

Last Trade: C$ 1.30
Volume: 200
5-Day Change: 0%
YTD Change: 0%
Market Cap: -

Latest News From Hamilton Thorne

BEVERLY, Mass. and TORONTO, March 27, 2024 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX: HTL), a leading provider of precision instruments, laboratory equipment, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today reported audited financial results for the fourth quarter and year-ended December 31, 2023. Financial Highlights Sales for the year... Read More
BEVERLY, Mass. and TORONTO, March 21, 2024 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX: HTL), a leading provider of precision instruments, laboratory equipment, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that it will release its financial results for the three and twelve months ended December 31, 2023 before market open on... Read More
BEVERLY, Mass. and TORONTO, Dec. 21, 2023 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced the appointment, of Dr. Ekaterina (Kate) Torchilin as its new President and Chief Executive Officer, effective January 15, 2024. Dr. Torchilin is... Read More
BEVERLY, Mass. and TORONTO, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that it will release its financial results for the three and nine months ended September 30, 2023 before market open on Monday, November 13, 2023. The... Read More
BEVERLY, Mass. and TORONTO, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced its graduation from the TSX Venture Exchange to the Toronto Stock Exchange (TSX) main board, effective September 7, 2023. Hamilton Thorne’s symbol... Read More
BEVERLY, Mass. and TORONTO, Aug. 17, 2023 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today reported audited financial results for the quarter and six months ended June 30, 2023. Financial Highlights Sales increased 15% year over year to $16.4 million... Read More
BEVERLY, Mass. and TORONTO, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that it will release its financial results for the three and six months ended June 30, 2023 before market open on Thursday, August 17, 2023. The press... Read More
BEVERLY, Mass. and TORONTO, May 15, 2023 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today reported financial results for the quarter ended March 31, 2023. Financial Highlights 1st quarter sales increased 19% to $16.7 million; sales for the quarter... Read More
BEVERLY, Mass. and TORONTO, May 08, 2023 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that it will release its financial results for the three months ended March 31, 2023 before market open on Monday, May 15, 2023. The press release,... Read More
BEVERLY, Mass. and TORONTO, April 13, 2023 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. ( TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that the Company will participate in the Bloom Burton & Co. Healthcare Investor Conference on April 25-26, 2023. David Wolf, President and CEO and... Read More
BEVERLY, Mass. and TORONTO, March 30, 2023 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today reported audited financial results for the fourth quarter and year-ended December 31, 2022. Financial Highlights 2022 sales increased 11% to a record $58.2... Read More
BEVERLY, Mass. and TORONTO, March 23, 2023 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX-V:HTL), a leading global provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that it will release its financial results for the three months and year-ended December 31, 2022 before market open on Thursday, March 30,... Read More
Revenue of $58.2 million for the year and $16.4 million for the 4 th quarter; Adj. EBITDA of approximately $10.1 million for the year and $3 million for the quarter BEVERLY, Mass. and TORONTO, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX-V:HTL), a leading global provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology... Read More
BEVERLY, Mass. and TORONTO, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX-V: HTL) ("Hamilton Thorne" or the "Company"), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies ("ART") research, and cell biology markets, today announces the passing of Diarmaid Douglas-Hamilton, Cofounder and Chief Technology Officer of Hamilton Thorne. Diarmaid... Read More

COPYRIGHT ©2023 HEALTH STOCKS HUB